Our article, Adding value to the government’s mandated QR code on all APIs, has been published in Biopectrum. Authored by Santosh Narayanan BT, Senior Business Analyst Consulting, Navitas Life Sciences, the article addresses the Government of India’s (GSR20(E)) mandate that a QR code be affixed to all Active Pharmaceutical Ingredients (APIs) manufactured or imported to India. The requirement will come live from 1st January 2023.
The mandate has been brought in as an effort to combat the issue of counterfeit medicines in India. According to available statistics, up to 20% of drugs manufactured in India are counterfeit, and, as per a government report, up to 3% of manufactured drugs are of substandard quality.
Please complete the form to download the article and learn more.
Published by BioSpectrum | 21 December, 2022
|Santosh Narayanan BT|
Senior Business Analyst Consulting
Navitas Life Sciences